|
CN108728444A
|
|
Immunoregulation polynucleotide and its application
|
|
CN106474143A
|
|
Toll-like receptor TLR7 and TLR9 inhibition oligonucleotides are preparing for treating the application in terms of the medicine of B cell lymphoma
|
|
CN105214083A
|
|
Pharmaceutical composition containing CpG ODN
|
|
JP2014073126A
|
|
One kind of oligonucleotide and application thereof
|
|
WO2014082254A1
|
|
Inhibitory oligonucleotide and use thereof
|
|
EP2154144A1
|
|
Oligonucleotides and use thereof
|
|
US2010035972A1
|
|
Oligonucleotide and use thereof
|
|
CA2638176A1
|
|
Oligonucleotide and use thereof
|
|
CN102703447A
|
|
Oligonucleotide with breast cancer treatment effect
|
|
CN101333237A
|
|
Oligonucleotide with breast carcinoma treating function
|
|
CN101240271A
|
|
Toll-like receptor adjustment oligonucleotide and use thereof
|
|
CN101161288A
|
|
Enhanced tumour cell cracking article of oligonucleotide and application thereof in preparing medicine for treating tumour
|
|
CA2609062A1
|
|
Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating b cell neoplasm
|
|
CN1847256A
|
|
Antiviral prepn containing both CpG single-strand deoxyoligonucleotide and ribavirin
|
|
EP2264046A1
|
|
Artificial CpG single-stranded oligodeoxynucleotide and antiviral use thereof
|
